Related Experiment Video
Updated: Aug 30, 2026

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment
Published on: May 25, 2020
Treatment of acute and chronic heart failure
1University of Texas College of Pharmacy, Austin, USA.
Insights
Heart failure management involves patient education on sodium restriction and daily weight monitoring. Standard treatment includes diuretics, ACE inhibitors, beta-blockers, and digoxin, with other medications for specific conditions.
Area of Science:
- Cardiology
- Internal Medicine
Background:
- Heart failure is a prevalent, expensive, and often fatal condition.
- Commonly caused by coronary artery disease or hypertension.
- Requires significant patient education and management.
Framework:
- Standard therapy includes diuretics, ACE inhibitors, beta-blockers, and digoxin.
- Patient education is crucial, emphasizing sodium restriction and daily weight monitoring.
- Combination therapy is the cornerstone of heart failure treatment.
Implementation:
- Administer diuretics, ACE inhibitors, beta-blockers, and digoxin as standard care.
- Educate patients on lifestyle modifications like sodium restriction and daily weight monitoring.
- Tailor treatment with anticoagulants or ARBs for specific patient profiles.
Implications:
- Effective management can improve outcomes for heart failure patients.
- Ongoing research into new medications and devices promises further advancements.
- Addresses the significant burden of heart failure on healthcare systems.
Abstract:
Heart failure is a common, costly, and generally fatal condition that most often results from coronary artery disease or hypertension. All patients with heart failure need education about the importance of sodium restriction and daily weight monitoring. Most patients with heart failure require combination therapy that includes a diuretic, an ACE inhibitor, a beta-blocker, and digoxin. Selected patients may benefit from alternative or additional medications, such as anticoagulants in individuals with atrial fibrillation or ARBs in those who cannot tolerate ACE inhibitor therapy. Investigational medications and devices for heart failure are under active study.
Related Concept Videos
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure Drugs: β-Blockers
Heart Failure VII: Nursing Interventions
